Dorothee Alatorre

Dorothee Alatorre is an accomplished professional in regulatory affairs with a diverse background spanning over a decade. Currently serving as Senior Director of Regulatory Affairs at Corcept Therapeutics since May 2024, Alatorre has held key positions at Allogene Therapeutics, CytomX Therapeutics, and BeiGene, where roles included Director and Associate Director in Regulatory Affairs. Prior experience includes Senior Regulatory Affairs Associate positions at Medivation and an internship focused on Clinical Regulatory Affairs at Genentech. Alatorre's academic foundation includes a PhD in Virology from Heidelberg University, an MSc in Biotechnology from Technische Universität Berlin, and a certification in Clinical Development Biotechnology from San Francisco State University. Research contributions include significant findings on lipid-droplet binding proteins and their role in Hepatitis C virus replication during postdoctoral studies at UCSF and The Gladstone Institutes.